Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research

Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research

Intermittent androgen deprivation therapy (IADT) is an alternative to continuous androgen deprivation therapy (ADT) in prostate cancer patients with nonmetastatic disease. ADT is associated with numerous side effects such as hot flashes, sexual dysfunction, anemia, fatigue, loss of muscle mass, oste...

Full description

Bibliographic Details
Main Authors: Rahul A Parikh, Laura E Pascal, Benjamin J Davies, Zhou Wang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-08-01
Series:Asian Journal of Andrology
Subjects:
5 alpha-reductase inhibitor; androgen-responsive genes; intermittent androgen deprivation therapy (IADT); prostate cancer; testosterone
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=505;epage=510;aulast=Parikh

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=505;epage=510;aulast=Parikh

Similar Items